Related Experiment Video
Updated: Jul 15, 2025

10:08
Phase Behavior of Charged Vesicles Under Symmetric and Asymmetric Solution Conditions Monitored with Fluorescence Microscopy
Published on: October 24, 2017
9.2K
Comprehensive Regulation of Liquid-Liquid Phase Separation of Polypeptides
Yanwei Wang1, Dongxin Xiang1, Siyuan Chen1
1Department of Physics, Wenzhou University, Wenzhou 325035, China.
Molecules (Basel, Switzerland)
|September 28, 2023
Summary
Liquid-liquid Phase Separation (LLPS) in peptides is regulated by length and salt concentration, with longer peptides requiring higher salt. Both hydrophobic and electrostatic interactions jointly drive this crucial cellular process.
Area of Science:
- Biochemistry
- Molecular Biology
- Biophysics
Background:
- Liquid-liquid Phase Separation (LLPS) of proteins and nucleic acids is vital for cellular functions and implicated in diseases.
- Understanding the molecular drivers of LLPS is essential for biological insight and therapeutic development.
Purpose of the Study:
- To investigate the regulation of LLPS in proline-arginine (PR) peptides by varying peptide length and salt concentration.
- To identify the specific molecular forces, including hydrophobicity and electrostatics, that drive peptide LLPS.
Main Methods:
- Systematic modification of repetitive PR peptide lengths.
- Alteration of solution salt concentrations and dielectric constant using ethyl alcohol and 6-Aminocaproic acid.
- Introduction of hydrophobic disruptors like 1,6-hexanediol.
Main Results:
- A threshold of eight PR repeats was identified, requiring higher salt concentrations for LLPS.
- Ethyl alcohol enhanced LLPS of PR15 by intensifying electrostatic interactions, while 6-Aminocaproic acid inhibited it.
- Hydrophobicity and electrostatic interactions were found to conjointly drive LLPS in these peptide systems.
Conclusions:
- Peptide length and solution conditions significantly regulate LLPS.
- LLPS is driven by a combination of hydrophobic and electrostatic forces.
- Findings offer guidance for manipulating LLPS in other peptide/protein systems and addressing related diseases.

